Top

European Radiology

Published in:

01-11-2012 | Neuro

Identification of mineral deposits in the brain on radiological images: a systematic review

Authors: Maria del C. Valdés Hernández, Lucy C. Maconick, Elizabeth M. J. Tan, Joanna M. Wardlaw

Published in: European Radiology | Issue 11/2012

Abstract

Objectives

MRI has allowed the study of mineral deposition in the brain throughout life and in disease. However, studies differ in their reporting of minerals on MRI for reasons that are unclear.

Methods

We conducted a systematic review from 1985 to July 2011 to determine the appearance of iron, calcium, copper and manganese on MRI and CT and their reliability. We assessed which imaging investigations provided the most consistent results compared with histology.

Results

Of 325 papers on minerals imaging, we included 46 studies that confirmed findings either directly or indirectly using a non-imaging method such as histology. Within this group, there was inconsistency in the identification of iron probably because of changes in its paramagnetic properties during its degradation. Iron appeared consistently hypointense only on T2*-weighted MRI, and along with calcified areas, hyperattenuated on CT. Appearance of copper, calcium and manganese, although consistently reported as hyperintense on T1-weighted MRI, was confirmed histologically in few studies. On T2-weighted imaging, calcified areas were always reported as hypointense, while the appearance of iron depended on the concentration, location and degradation stage.

Conclusions

More work is required to improve the reliability of imaging methods to detect and differentiate brain mineral deposition accurately.

Key Points

• There is inconsistency in reporting the appearance of minerals on radiological images.

• Only 46 studies confirmed mineral appearance using a non-imaging method.

• Iron is the mineral more widely studied, consistently hypointense on T2*-weighted MRI.

• T1-weighted MRI consistently reported copper, calcium and manganese hyperintense.

• Calcium is consistently reported hypointense on T2-weighted MRI and hyperattenuating on CT.

Available only for authorised users

Aquino D, Bizzi A, Grisoli M et al (2009) Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 252:165–172PubMedCrossRef

Miyajima H, Takahashi Y, Kono S (2003) Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 16:205–213PubMedCrossRef

O’Brien C, Sung JH, McGeachie RE, Lee MC (1990) Striatonigral degeneration: clinical, MRI and pathologic correlation. Neurology 40:710–711PubMedCrossRef

Duckett S, Galle P, Escourolle R, Poirier J, Hauw JJ (1977) Presence of zinc, aluminium, magnesium in striopalledodentate (SPD) calcifications (Fahr’s disease): electron probe study. Acta Neuropathol 38:7–10PubMedCrossRef

De Reuck J, Auger F, Cordonnier C et al (2011) Comparison of 7.0 T T2*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis 31:511–517PubMedCrossRef

Schenck JF, Zimmerman EA (2004) High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 17:433–445PubMedCrossRef

Schenck JF, Zimmerman EA, Li Z et al (2006) High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging 17:41–50PubMedCrossRef

Penke L, Valdés Hernández MC, Maniega SM et al (2012) Brain iron deposits are associated with general cognitive ability and cognitive aging. Neurobiol Aging 33:510–517PubMedCrossRef

Duckett S (1991) Neuroradiology. In: Lea & Febiger (eds) The pathology of the aging human nervous system, 1st edn. Lea & Febiger, Philadelphia, pp 492

10.

Casanova MF, Araque JM (2003) Mineralisation of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res 121:59–87PubMedCrossRef

11.

Crompton DE, Chinnary PF, Fey C et al (2002) Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells Mol Dis 29:522–531PubMedCrossRef

12.

Haacke EM, Cheng NY, House MJ et al (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23:1–25PubMedCrossRef

13.

Ropele S, de Graaf W, Khalil M et al (2011) MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 34:13–21PubMedCrossRef

14.

Alafuzoff I (2008) Cerebral amyloid angiopathy, hemorrhages and superficial siderosis. Stroke 39:2699–2700PubMedCrossRef

15.

Akutsu H, Tsuboi K, Sakamoto N, Nose T, Honma S, Jikuya T (2004) Cerebral metastasis from angiosarcoma of the aortic wall: case report. Surg Neurol 61:68–71PubMedCrossRef

16.

Allkemper T, Reimer P, Schueirer G, Peters PE (1998) Study of susceptibility-induced artefacts in GRASE with different echo train length. Magn Reson Imaging 8:834–838

17.

Barkhof F, Verrips A, Wesseling P et al (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217:869–876PubMed

18.

Bizzi A, Brooks RA, Brunetti A et al (1990) Role of iron and ferritin in MR imaging: a study on primates at different field strengths. Radiology 177:59–65PubMed

19.

Boddaert N, Le Quan Sang KH, Rötig A et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110:401–408PubMedCrossRef

20.

Brass SD, Chen N, Mulkern RD, Bakshi R (2006) Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 17:31–40PubMedCrossRef

21.

Brooks DJ, Luthert P, Gadian D, Marsden CD (1989) Does signal-attenuation on high-field MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. J Neurol Neurosurg Psychiatry 52:108–111PubMedCrossRef

22.

Curtis AR, Fey C, Morris CM et al (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28:350–354PubMedCrossRef

23.

El Tannir El Tayara N, Wolk A, Dhenain M, Delatour B (2007) Transverse relaxation time reflects brain amyloidosis in young APP/PS1 transgenic mice. Magn Reson Med 58:179–184CrossRef

24.

El Tannir El Tayara N, Delatour B, Le Cudennec C, Guegan M, Volk A, Dhenain M (2006) Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer’s disease. Neurobiol Dis 22:199–208PubMedCrossRef

25.

Fazekas F, Kleinert R, Roob G et al (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2* weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 20:637–642PubMed

26.

Feldman HH, Maia LF, Mackenzie IRA, Forster BB, Martzke J, Woolfenden A (2008) Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 39:2894–2897PubMedCrossRef

27.

Gelman N, Gorell JM, Barker PB et al (1999) MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 210:759–767PubMed

28.

Higano S, Takahashi S, Kurihara N et al (1997) Supratentorial primary intra-axial tumors in children. MR and CT evaluation. Acta Radiol 38:945–952PubMed

29.

Hocq A, Brouette N, Saussez S, Luhmer M, Gillis P, Goussin Y (2009) Variable-field relaxometry of iron-containing human tissues: a preliminary study. Contrast Media Mol Imaging 4:157–164PubMedCrossRef

30.

Jack CR, Wengenack TM, Reyes DA et al (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer’s transgenic mice. J Neurosci 25:10041–10048PubMedCrossRef

31.

Janss AJ, Galetta SL, Freese A et al (1993) Superficial siderosis of the central nervous system: magnetic resonance imaging and pathological correlation. Case report. J Neurosurg 79:756–760PubMedCrossRef

32.

Kawanami T, Kato T, Tominaga M et al (1996) Hereditary ceruloplasmin deficiency: clinicopathological study of a patient. J Neurol Neurosurg Psychiatry 61:506–509PubMedCrossRef

33.

Ketonen L, Keiburtz K, Kazee AM, Tuite M (1996) Putaminal iron deposition in HIV infection. J NeuroAIDS 1:33–40PubMed

34.

Kruer MC, Hiken M, Gregory A et al (2011) Novel histopathological findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. Brain 134:947–958PubMedCrossRef

35.

Langkammer C, Krebs N, Goessler W et al (2010) Quantitative MR imaging of brain iron: a post-mortem validation study. Radiology 257:455–462PubMedCrossRef

36.

Maeda H, Sato M, Yoshikawa A et al (1997) Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 39:546–550PubMedCrossRef

37.

Meadowcroft MD, Connor JR, Smith MB, Yang QX (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer’s disease and APP/PS1 transgenic mice. J Magn Reson Imaging 29:997–1007PubMedCrossRef

38.

Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N (2001) Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57:2205–2210PubMedCrossRef

39.

Morita H, Ikeda S, Yamamoto K et al (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 37:646–656PubMedCrossRef

40.

Ogg RJ, Steen RG (1998) Age related changes in brain T1 are correlated with putative iron concentration. Magn Reson Med 40:749–753PubMedCrossRef

41.

Onyszchuk G, Levine SM, Brooks WM, Berman NE (2009) Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci Lett 452:204–208PubMedCrossRef

42.

Reimer P, Allkemper T, Schuierer G, Peters RE (1996) Brain imaging: reduced sensitivity of RARE-derived techniques to susceptibility effects. J Comput Assist Tomogr 20:201–205PubMedCrossRef

43.

Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S, Hoehn M (2004) Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed 17:163–169PubMedCrossRef

44.

Schrag M, McAuley G, Pomakian J et al (2009) Correlation of hypointensities in susceptibility weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a post-mortem MRI study. Acta Neuropathol 119:291–302CrossRef

45.

Schroeter M, Saleh A, Wiedermann D, Hoehn M, Jander S (2004) Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia. Magn Reson Med 52:403–406PubMedCrossRef

46.

Takeuchi Y, Yoshikawa M, Tsujino T et al (2002) A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J Neurol Neurosurg Psychiatry 72:543–545PubMed

47.

Tuite PJ, Provias JP, Lang AE (1996) Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease and some pathological features of Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry 61:523–527PubMedCrossRef

48.

Vymazal J, Brooks RA, Baumgarner C et al (1996) The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 35:56–61PubMedCrossRef

49.

Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 211:489–495PubMed

50.

Wu G, Xi G, Hua Y, Sagher O (2010) T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral haemorrhage. Transl Stroke Res 1:31–34PubMedCrossRef

51.

Sue CM, Crimmins DS, Soo YS et al (1998) Neuroradiological features of six kindreds with MELAS tRNA (Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry 65:233–240PubMedCrossRef

52.

Chaki H, Furuta S, Matsuda A et al (2000) Magnetic resonance image and blood manganese concentration as indices for manganese content in the brain of rats. Biol Trace Elem Res 74:245–257PubMedCrossRef

53.

Fitsanakis VA, Zhang N, Anderson JG et al (2008) Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 103:116–124PubMedCrossRef

54.

Fitsanakis VA, Zhang N, Anderson JG et al (2011) Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol Sci 120:146–153PubMedCrossRef

55.

Finkelstein Y, Zhang N, Fitsanakis VA, Avison MJ, Gore JC, Aschner M (2008) Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study. Isr Med Assoc J 10:793–798PubMed

56.

Wang X, Qian J, He R et al (2006) Delayed changes in T1-weighted signal intensity in a rat model of 15-minute transient focal ischemia studied by magnetic resonance imaging/spectroscopy and synchrotron radiation X-ray fluorescence. Magn Reson Med 56:474–480PubMedCrossRef

57.

Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41–51PubMedCrossRef

58.

Loeffer DA, Connor JR, Juneau PL et al (1995) Transferrin and iron in normal, Alzheimer’s disease and Parkinson’s disease brain regions. J Neurochem 65:710–724CrossRef

Title: Identification of mineral deposits in the brain on radiological images: a systematic review
Authors: Maria del C. Valdés Hernández
Lucy C. Maconick
Elizabeth M. J. Tan
Joanna M. Wardlaw
Publication date: 01-11-2012
Publisher: Springer-Verlag
Published in: European Radiology / Issue 11/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-012-2494-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Identification of mineral deposits in the brain on radiological images: a systematic review

Abstract

Objectives

Methods

Results

Conclusions

Key Points

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 11/2012

Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation

Advanced MR methods at ultra-high field (7 Tesla) for clinical musculoskeletal applications

Differences in the location and activity of intestinal Crohn’s disease lesions between adult and paediatric patients detected with MRI

A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research

Prevalence of cartilage lesions and early osteoarthritis in patients with patellar dislocation

Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn’s disease activity: a preliminary study